Государственный научный центр лекарственных средств
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Державний Науковий Центр Лікарських Засобів, Государственный научный центр лекарственных средствfiledCriticalДержавний Науковий Центр Лікарських Засобів
Priority to UA97125871ApriorityCriticalpatent/UA43413C2/en
Publication of UA43413C2publicationCriticalpatent/UA43413C2/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Invention relates to the chemical and pharmaceutical industry, in particular, to the methods of obtaining the injection means for treating the cardiovascular diseases. The method of obtaining the injection means for treating the cardiovascular diseases includes the dissolution of active material in the presence of stabilizer, filtration, ampulation and sterilization of the obtained solution. Used as the active material erikhrozid is dissolved in the aqueous lemon-phosphate buffer solution from pH 6,0-7,0 at a temperature of 40-500C with the addition as the stabilizer of trilon B in concentration 0,0025-0,005 %, and sterilization conducts with 1000C for a period of 30 minutes. .
UA97125871A1997-12-081997-12-08Method for obtaining the injection means "erikhrozid" for treating the cardiovascular diseases
UA43413C2
(en)
DETOXIFIED IMMUNOGENIC ANTIBODIES DIRECTED AGAINST A RETROVIRAL REGULATORY PROTEIN, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE IMMUNOGENE OR ANTIBODIES.
Process for the preparation of a pharmaceutical composition comprising 5-aminosalicylic acid for use in the treatment of ulcerative colitis and Crohn's disease